These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 5375576)

  • 21. [Value of quantitative bacteriological examination of sputum in the evaluation of the effectiveness of chemotherapy of bacterial respiratory tract infections. II. Clinical studies].
    Nikodemowicz E; Owsiński J; Przybyłkiewicz Z; Kasprowicz A; Maternowska W; Kamińska M; Walaszek K; Prus F
    Pneumonol Pol; 1980 Aug; 48(8):545-22. PubMed ID: 6968434
    [No Abstract]   [Full Text] [Related]  

  • 22. The diagnosis and treatment of upper respiratory symptoms produced by increased viscosity of mucus and dryness of the mucous membranes.
    ANDERSON JR; RUBIN W
    Laryngoscope; 1956 Jan; 66(1):85-92. PubMed ID: 13287141
    [No Abstract]   [Full Text] [Related]  

  • 23. [Problems of collecting specimens for the diagnosis of respiratory infection].
    Matsumoto K
    Rinsho Byori; 1970 Sep; 18(9):Suppl:19. PubMed ID: 5466302
    [No Abstract]   [Full Text] [Related]  

  • 24. Azlocillin and gentamicin in respiratory tract infections with Pseudomonas aeruginosa in patients with cystic fibrosis.
    Malmborg AS; Alfredsson H; Kusoffsky E; Strandvik B
    Scand J Infect Dis Suppl; 1981; 29():64-9. PubMed ID: 6947407
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Rheologic study of sputum].
    Molina C; Aiache JM; Pradelle ; Cheminat JC
    Presse Med (1893); 1970 Aug; 78(36):1576. PubMed ID: 5456288
    [No Abstract]   [Full Text] [Related]  

  • 26. [In-vitro studies with the secretolytic agent Bisolvon (supplement to preliminary clinico-experimental experiences)].
    Bürgi H
    Praxis; 1965 Nov; 54(45):1327-30. PubMed ID: 5899263
    [No Abstract]   [Full Text] [Related]  

  • 27. [On the mechanism of the mucolytic action of N-acetyl-L-cysteine].
    Galzigna L; Reggiani A
    Boll Soc Ital Biol Sper; 1965 Jan; 41(1):54-6. PubMed ID: 5875804
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effect of a secretolytic agent (bromhexine) on the penetration of erythromycin into bronchial secretions].
    Bergogne-Berezin E; Pierre J; Dournovo P
    Fortschr Med; 1982 Jun; 100(24):1169-71. PubMed ID: 7049878
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment of infections of the respiratory tract with Terramycin aerosol (Pfizer)].
    Wojciechowski F; Podleski WK
    Pol Tyg Lek; 1971 Feb; 26(5):182-4. PubMed ID: 5546493
    [No Abstract]   [Full Text] [Related]  

  • 30. [Biochemical mode of action of cysteine by-products on the bronchial mucus].
    Havez R; Degand P; Roussel P; Randoux A
    Poumon Coeur; 1970; 26(1):81-90. PubMed ID: 5421538
    [No Abstract]   [Full Text] [Related]  

  • 31. The principles of drug action on cough and on sputum characteristics.
    Richardson PS
    Eur J Respir Dis Suppl; 1980; 110():67-79. PubMed ID: 6938393
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical evaluation of new therapies for treatment of mucus hypersecretion in respiratory diseases.
    Disse B
    Novartis Found Symp; 2002; 248():254-72; discussion 272-6, 277-82. PubMed ID: 12568499
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment of cough in acute respiratory virus infections and influenza by the patients of risk group].
    Kliachkina IL
    Voen Med Zh; 2009 Jul; 330(7):40-5. PubMed ID: 19827667
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapy for intercurrent respiratory infections in COLD patients: report on 200 patients.
    Turco P; Pomari C; Zoccatelli O; Trevisan F; Carloni C; Dal Negro RW
    Int J Clin Pharmacol Ther Toxicol; 1983 May; 21(5):260-2. PubMed ID: 6862731
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Objective criteria for evaluation of mucolytic agents.
    Bürgi H
    Bibl Paediatr; 1967; 86():339-43. PubMed ID: 4228298
    [No Abstract]   [Full Text] [Related]  

  • 36. [On the action of different concentrations of urea on human erythrocytic angiotensinase activity in vitro].
    Ripa R; Degli Atti B; Baggioni GF
    Minerva Med; 1969 Dec; 60(102):5209-12. PubMed ID: 4322987
    [No Abstract]   [Full Text] [Related]  

  • 37. A simple method of measuring sputum viscosity.
    Jenssen AO
    Scand J Respir Dis; 1973; 54(5):290-6. PubMed ID: 4777382
    [No Abstract]   [Full Text] [Related]  

  • 38. In vitro study of mucolytic action of urea on sputum.
    Chaubey BS; Malpe SS
    Indian J Chest Dis; 1969 Jul; 11(3):127-31. PubMed ID: 5375576
    [No Abstract]   [Full Text] [Related]  

  • 39. In vitro evaluation of the mucolytic action of urea.
    Lieberman J
    JAMA; 1967 Nov; 202(8):694-6. PubMed ID: 6072512
    [No Abstract]   [Full Text] [Related]  

  • 40. The evaluation of mucolytic drugs in chronic bronchitis.
    Shelley JH
    Br J Clin Pract; 1970 Dec; 24(12):533-8. PubMed ID: 4924491
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.